In particular, nine valuable genes, namely, IRF7, IFI35, IFIT3, ISG15, OAS1, MX2, OASL, IFITM1, and IFIH1, were identified as potential biomarkers for the diagnosis and assessment of the disease activity of patients with SLE. This evidence concerns the gene IFITM1 and systemic lupus erythematosus.